US Patent Issued to Deciphera Pharmaceuticals on Aug. 18 for "Amorphous kinase inhibitor formulations and methods of use thereof" (Oregon, Massachusetts Inventors)

ALEXANDRIA, Va., Aug. 18 -- United States Patent no. 12,708,617, issued on Aug. 18, was assigned to Deciphera Pharmaceuticals LLC (Waltham, Mass.).

"Amorphous kinase inhibitor formulations and methods of use thereof" was invented by Michael D. Kaufman (Waltham, Mass.), Scott Bone (Bend, Ore.), Corey Bloom (Bend, Ore.) and Fred Jordan (Bend, Ore.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein is an amorphous compound represented by Formula (I):and compositions thereof, which are useful in the treatment of disorders related to the activity of the c-KIT and PDGFRAlpha kinases, and oncogenic forms thereof."

The patent was filed on Sept. 8, 2023, under Application No. 18/463,498.

*For further in...